New treatment option for Dehydration
Official title Adequate Hydration and Health Outcomes
ClinicalTrials.gov ID: NCT07179107
What this study is testing
- What it's testing
- Cardiovascular diseases (CVD) are the leading cause of death in middle- and high-income countries, according to data from the World Health Organization (WHO). Epidemiological studies have associated low water intake and underhydration with diabetes, chronic kidney disease, and an increased risk of CVD.
- This is a blinded study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 65. Healthy volunteers may be eligible.
You may be able to join if
- BMI 18.5-24.9 or 30.0-39.9 kg/m2
- HbA1c ≤7%
- Age 20-65 y
- available for 8 consecutive weeks same day and time
You likely can't join if
- Diabetes
- HbA1c \>7% BMI ≤18.5, BMI of 25 to \<30, or ≥ 40 kg/m2
- night shifting work
- losing or gaining weight during the last 2 months (\>5 lbs. fluctuation)
- thyroid medication
- bariatric surgery
See the full eligibility criteria
- BMI 18.5-24.9 or 30.0-39.9 kg/m2
- HbA1c ≤7%
- Age 20-65 y
- available for 8 consecutive weeks same day and time
- Diabetes
- HbA1c \>7% BMI ≤18.5, BMI of 25 to \<30, or ≥ 40 kg/m2
- night shifting work
- losing or gaining weight during the last 2 months (\>5 lbs. fluctuation)
- thyroid medication
- bariatric surgery
- Habitual strenuous exercise (\>120 min/week) Strenuous exercise is defined as activities that take hard physical effort and make you breathe much harder than normal.
- Construction and other workers that spend signifant portion of their work day outdoors
- Commuting by bicycle
- Eating disorders
- Use of aspirin during the duration of the study
- Cancer
- Renal disease (including kidney stones or recurrent urinary track infections
- Hepatic disease
- Cardiac conditions
- Current infection requiring medication
- Chronic, contagious, infectious diseases such as tuberculosis, Hepatitis A, B, C, or HIV
- Medication that could affect appetite or body weight regulation
- GLP1-RA medication
- Anti-depressent SSRI medication
- Testosterone replacement therapy
- Participating in another study at the same time
- Unable to abstain from alcohol during the study
- Unable to limit caffeinated beverage intake to 1 cup per day
- Donated blood during the past two months
- Uneasibly acessable veins
- Does not have smart phone
The study team makes the final eligibility decision.
Where it's taking place
- Phoenix, Arizona, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years to 65 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Phoenix, Arizona, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.